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ABSTRACT
The main problem in the culture of clown loach (Chromobotia macracanthus) is the slow growth rate, which
takes about six months to reach its market size (two inches total body length). Slow growth eventually
cause a long production time and increase the production costs. An alternative solution can be proposed
in order to enhance the growth is by using recombinant growth hormone. The aim of this study was to
determine the immersion dose of recombinant Epinephelus lanceolatus growth hormone (rElGH) which can
generate the highest growth in clown loach. Larvae at seven day after hatching were hyperosmotic treated
with NaCl 2.0% for one minute, then immersed for one hour in water containing 0.3% NaCl, 0.01% bovine
serum albumin (BSA), and different doses of rElGH, namely: 0.12 (treatment A), 1.2 (B), 12 (C), and 120 mg/
L (D). As control, fish were immersed in water without rElGH and NaCl (control-1), water containing 0.3%
NaCl and 0.01% BSA (control-2), and 0.3% NaCl water (control-3). Each treatment was replicated three times.
The results showed that clown loach juveniles in treatment B, C, and D had longer total body length
(P<0.05) than control-1, while fish treatment A was the same as controls. Survival and body weight were
similar in all treatments and controls (P>0.05). In addition, the percentage of large size juveniles increased
approximately 5% in treatment B, almost the same as in the medium size, while the small size were decrease
compared to the control-1. Thus, the best immersion dose of rElGH was 1.2 mg/L water.
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INTRODUCTION
Administration of recombinant growth hormone
(rGH) has been reported as an effective way to in-
crease fish growth, and mainly applied to fish for food.
In ornamental fish, effectiveness of rGH treatment
has been reported in goldfish (Promdonkoy et al.,
2004; Acosta et al., 2009) and angelfish (Pterophyllum
scalare) (Acosta et al., 2009). Several recombinant
growth hormone (rGH) of fish had recently been pro-
duced, such as giant catfish rGH (Promdonkoy et al.,
2004), salmon rGH (Moriyama & Kawauchi, 1990), ti-
lapia rGH (Acosta et al., 2007), giant gourami and gi-
ant grouper rGH (Alimuddin et al., 2010). Among three
rGH fish species produced in Indonesia, recombinant
Epinephelus lanceolatus growth hormone (rElGH) is
widely used because its production level on E. coli is
higher compared with Cyprinus carpio (rCcGH) and
Osphronemus goramy (rOgGH) (Irmawati, 2013). In
addition, bioactivity of rElGH in terms of growth
stimulation on tilapia is better than rCcGH and rOgGH
(Alimuddin et al., 2010).
Recombinant growth hormone can be delivered
by injection (Promdonkoy et al., 2004), orally via feed
(Peterson et al., 2004), immersion (Acosta et al.,
2007), and combination of immersion and oral meth-
ods (Handoyo, 2012). Immersion method is the most
applicable to be executed on a mass scale at larval
stage. Effectiveness of rGH delivery by immersion is
determined by the dose and duration of treatment.
Aminah (2012) reported that administration of rEIGH
on eel fry by immersion for two hours at a dose of 3
mg/L, can increase biomass by 28% and survival of
15.2% higher than the control. Furthermore, immer-
sion of eel fry in water containing rElGH for two hours
at a dose 12 mg/L can increase growth by 37.4% higher
than control (Handoyo, 2012). Meanwhile, immersion
of white shrimp PL2 in 15 mg/L rElGH solution for
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three hours increases body weight of 109.9%; body
length of 26.0%; and biomass of 66.0% higher com-
pared to the control (Subaidah et al., 2012).
Clown loach aquaculture has been successfully car-
ried out in Research and Development Institute for
Ornamental Fish Culture, Depok (Satyani et al., 2006).
The main problems occurred in clown loach culture
is the slow growth rate, which takes about six months
to reach two inches of body length (Permana et al.,
2011). Therefore, efforts are needed in order to en-
hance the growth and shorten the rearing period of
clown loach. In this study, as the first step to de-
velop an effective rGH delivery method for clown lo-
ach, rElGH was delivered by immersion method to
obtain an optimum dose that allows higher growth
of clown loach juvenile.
MATERIALS AND METHODS
Recombinant Growth Hormone Production
Production of recombinant growth hormone was
conducted at Laboratory of Fish Reproduction and
Genetics, Department of Aquaculture, Faculty of Fish-
eries and Marine Sciences, IPB. Escherichia coli bacteria
BL21 containing pCold-I/ElGH constructs were cultured
and crude protein containing rElGH was extracted fol-
lowing the method of Alimuddin et al. (2010). Proteins
were washed with phosphate buffer saline and kept in
a deep freezer at -80°C until be used.
Experimental Design and Fish Rearing
Completely randomized design was used as the
experimental method on this study (Table 1). The ef-
fect of rElGH treatment was determined by analyzing
the daily growth rate (DGR) and survival of clown
loach immersed in rElGH solution compared with the
untreated fish (control). Larvae were hyperosmotic
treated in 2.0% NaCl sulution for one minute, then
immersed for one hour (based on preliminary re-
search) in water containing 0.3% NaCl, 0.01% BSA, and
rElGH with different doses (0.12, 1.2, 12, and 120
mg/L), with fish density of 5 larvae/L. As control, fish
were immersed in water without rElGH and NaCl (con-
trol-1), water containing 0.3% NaCl and 0.01% BSA (con-
trol-2), and 0.3% NaCl water (control-3). Three con-
trols were used for the purpose of ensuring that the
growth improvement caused only by rElGH. Each treat-
ment was replicated three times.
Seven-day-old larvae were obtained from Institute
for Research and Development for Ornamental Fish
Culture, Depok, with average body length of 0.57 cm
and body weight of 0.0019 g. Those fish were from
one broodstock. Fish were reared for 84 days in the
closed recirculating system tanks (80 cm x 40 cm x 20
cm) and fed at satiation with Artemia nauplii for the
first 30 day rearing, combination of Artemia nauplii
and bloodworm for the second 15 days rearing, and
bloodworm for the last 38 days rearing.
Parameters and Statistical Analysis
Parameters observed were weight daily growth rate
and length daily growth rate, absolute weight and length,
survival, and size variations. Fish weight and length
were measured every three weeks, about 30 individu-
als per replication. Weight daily growth rate (LPHb)
and length (LPHp) were calculated based on Effendie
(1997). LPHb = [(ln Wt - ln W0) /t x 100], LPHp = [(ln Pt
- ln P0) /t x 100]. Wt = average body weight at the end
of the experiment (g), W0 = average body weight at
the initial (g), Pt = average total body length at the
end of the experiment (mm), P0 = average total body
length at the initial (mm), t = duration of study period
(days). Fish survival was counted at the end of the
experiment. Fish size variations were measured at the
end of the study. Fish were grouped into three sizes
based on total body length (TL), small (S, TL= 15.5 ±
4.5 mm), medium (M, TL= 25.5 ± 4.5 mm), and large
sizes (L, TL= 35.5 ± 4.5 mm).
Data of growth, survival, and variations in size
were analyzed using analysis of variance (ANOVA) and
Tukey’s test using SPSS 17.0 software.
RESULTS AND DISCUSSION
Results
Figure 1 and Table 1 illustrated that total body
length of fish treatment B (1.2 mg /L), C (12 mg/L),
and D (120 mg/L) was longer (P<0.05) than the con-
trol-1, whereas treatment A (0.12 mg/L) was the same
as all controls. Growth length of clown loach were
decrease from treatment B, C, and D which the high-
est in growth obtained from treatment B, which is
7.3% faster than the control-1.
Absolute body weight and length, daily growth,
and survival rates of clown loach were presented in
Table 2. Table 2 showed that total body length and
length daily growth rate for the treatment B, C, and
D were significantly higher (P<0.05) than that of con-
trol-1. Total body length of fish treatment D was the
same (P>0.05) with the controls. On the other hand,
the administration of rElGH through immersion on
clown loach larvae did not significantly affect growth
rate of body weight, and survival.
Fish were immersed in water without rElGH and
NaCl (control-1), water containing 0.3% NaCl and 0.01%
BSA (control-2), and 0.3% NaCl water (control-3). Dif-
ferent superscript letters in the same row are statis-
tically different (P<0.05).
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A (0.12) B (1.2) C (12) D (120) E (control-1) F (control-2) G (control-3)
Total body 
length (mm)
26.55±0.75ab 27.32±0.31b 26.92±0.61b 26.89±0.44b 25.46±0.17a 26.56±0.87ab 26.53±0.53ab
Body 
weight (g) 2.763±0.294
a 2.907±0.156a 2.841±0.208a 2.898±0.088a 2.704±0.490a 2.824±0.199a 2.725±0.130a
Length growth 
rate (%) 1.832±0.033
ab 1.866±0.015b 1.848±0.027b 1.847±0.019b 1.782±0.007a 1.832±0.039ab 1.831±0.020ab
Weight growth 
rate (%)
8.669±0.125a 8.730±0.063a 8.702±0.087a 8.726±0.036a 8.643±0.202a 8.695±0.082a 8.653±0.057a
Survival 
rate (%)
82±7a 78±6a 90±5a 84±2a 76±4a 86±5a 82±2a
Parameters
rEIGH immersion doses (based on weight mass, mg/L)
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Clown loach body size at the end of the study was
grouped into three size, namely small (S), medium
(M), and large (L), and the results were presented in
Table 2. As shown on Table 2, the administration of
rElGH through immersion on clown loach larvae did
not affect (P>0.05) on variation of S and M size dis-
tribution, but significantly affect (P<0.05) on L size
distribution at the end of the study. The size group-
ing was conducted based on the mean of body length
and standard deviation, although this method actu-
ally has not been standardized yet, likewise on neon
tetra fish, tiger barb and other ornamental fish. This
size grouping was conducted only to distinguish size
variations that appear after three months of fish rear-
ing.
Recombinant growth hormone immersion was
conducted once at the beginning of rearing phase
with different doses. Different superscript letters in
the same row are statistically different (P<0.05). Size
S (small, TL = 15.5 ± 4.5 mm), M (medium, TL =
25.5 ± 4.5 mm), and L (large, TL = 35.5 ± 4.5 mm).
Discussion
Clown loach fish growth is relatively slow so the
time needed to reach market sizes (two inches or 5
Figure 1. Growth length of clown loach (Chromobotia macracanthus) treated
with different dosage of recombinan Epinephelus lanceolatus
growth hormone by immersion method
Table 1. Body weight and length, length daily growth rate (LDG), and weight (WGR), and survival rate of
clown loach juvenile on controls and treatment of recombinant Epinephelus lanceolatus growth hor-
mone immersion with different doses
Th
e 
av
er
ag
e 
of
 t
ot
al
 le
ng
th
 (m
m
)
Note: Fish were immersed in water without rEIGH an Nacl (control-1), water containing 0.3% Nacl and 0.01% BSA (control-2), and 0.3%
Nacl water (control-3). Different superscript letters in the same row are statically (P<0.05)
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A (0.12) B (1.2) C (12) D (120) E (control-1) F (control-2) G (control-3)
Size S (%) 30.7±2.9a 28.1±4.8a 27.6±3.1a 28.4±7.0a 34.4±10.7a 32.2±2.0a 29.9±2.0a
Size M (%) 36.4±4.4a 34.9±4.3a 36.9±4.1a 36.4±7.4a 33.3±12.0a 35.6±4.0a 37.9±3.5a
Size L (%) 33.0±1.8abc 37.1±0.7c 35.6±1.1abc 35.2±1.3abc 32.2±1.1ab 32.2±2.0ab 32.2±2.0ab
Fish 
size
rEIGH immersion dose (based on weight mass, mg/L)
cm) is relatively long. In this sudy, treatment of clown
loach by rElGH immersion at a dose of 1.2 mg/L in-
creased length growth rate by 7.3% compared to the
control-1 without rElGH immersion (P<0.05), while
the weight and daily growth rate did not show sig-
nificant difference (P>0.05). According to Figure 1,
length growth was still possibly increased and this
indicates the potential to be faster reach the size of
two inches. However, compared with other studies
on different commodities, these results are still lower.
This is presumably due to less immersion time.
Subaidah et al. (2012) obtained an increasing body
weight of white shrimp about 62.21% after rElGH
immersion treatment for three hours, and it is 2.3
higher than two hours of immersion treatment
(26.99%). High increase of growth rate can also be
obtained by combining rGH treatment at larval stage,
and oral treatment at juvenile stage (Handoyo, 2012).
Thus, longer immersion time and combination of
immersion and oral delivery method may allow higher
growth enhancement in clown loach.
Low growth stimulation in rGH treatment can also
due to low affinity of rGH on the receptor. Birzniece et
al. (2009) stated that different growth effect occurs
because the administered rGH was not suitable with
growth hormone receptors on target fish. In our study
the genetic relationship of recombinant growth hor-
mone of giant grouper is much distant with the clown
loach. However, Alimuddin et al. (2011) reported that
the weight of giant gourami immersed with recombi-
nant giant gourami growth hormone (rOgGH) show-
ing an escalation growth by 75% higher than the con-
trol. In other study, the use of rGH tilapia on tilapia
juveniles was able to increase the growth of more than
50% (Acosta et al., 2007). Those studies are using re-
combinant growth hormone from the same fish to
the test fish. Until now, GH of clown loach has not
been isolated yet, and only rElGH have been tested.
Length is a determining factor in the production
of ornamental fish because ornamental fish sales are
usually based on the body length. Based on these re-
sults, the growth of clown loach length can be in-
creased through immersion treatment at a dose of
1.2 mg/L. Thus the rElGH immersion treatment has a
high potential to be applied by aquaculturist in order
to increase production efficiency particularly rearing
time efficiency. If we see it from the length daily
growth rate point of view, treatment B can reach
market size (5 cm) within 117 days, it was faster one
week compared with controls (123 days), by looking
at the growth trends; it was still increasing until 3-
month-old. This also provide opportunity to reach
market size (5 cm) more quickly if the fish were ad-
ministered growth hormone again through oral on
clown loach juvenile that were already immersed with
growth hormone. Handoyo (2012) stated that the
response of eel treated with rGH treatment via im-
mersion and oral combination showing a significant
improvement of LPH (41.6%) and harvest biomass
(102.9%) compared to controls.
The enhancement of rElGH dosage from 0.12; 1.2;
12 to 120 mg/L was not positively correlated with an
increase on clown loach fish growth. The rElGH im-
mersion dose at 1.2 mg/L was better than 0.12; 12;
and 120 mg/L. This suggests that rElGH immersion with
a dose of 1.2 mg/L was optimum to spur the growth
of clown loach. Growth hormone administration on a
low dosage would not have a positive effect on growth;
conversely too high dose will have a negative effect
on fish hormonal feedback (Debnanth, 2010). Nega-
tive feedback is happened hormonally, in which IGF-1
will suppress the pituitary on producing GH, if the
concentrations of GH in the body is excessive.
In others control treatment, showing no signifi-
cant differences (P>0.05). This means that the ad-
ministration of 0.01% BSA and salinity shock does
not affect the growth of clown loach fish, as well as
the rElGH treatment at a dose 0.12 mg/L. The dose
of 0.12 rElGH mg/L allegedly too small and have not
been able to influence clown loach growth.
Table 2. Distribution of clown loach size variations (small/S, medium/M, and large/L) at the end of
the study on control and fish treated by recombinant Epinephelus lanceolatus growth hor-
mone with different doses
Note: Recombinant growth hormone immersion was conducted once at the beginning of reareing phase with different
doses. Different superscript letters in the sam row are statically different (P<0.05). Size S (small, TL= 15.5±4.5 mm),
M (medium, TL= 25.5±4.5 mm) and L (large, TL= 35.5±4.5 mm)
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At the end of the study, fish size distribution was
also observed and grouped into three sizes: small,
medium, and large. The result showed that the growth
was still relatively high at high rElGH dose, but not
followed by the variation of fish size distribution.
Percentage of large size fish in treatment dose of 1.2
mg/L was higher (P<0.05) compared to the control
(Table 3). Variation in fish size is an important factor,
especially in determining the amount of fish that can
be sold or not at harvesting time. More large fish
than medium and small sizes, so more fish that are
fit with the market size criteria. Surely it would be
more profitable for the business of clown loach fish
rearing.
Clown loach survival rate at the end of the study
was high (76%-90%), and not significantly different
between treatments (P>0.05). This high rate of sur-
vival is also due there was no infection or the pres-
ence of stress to environmental factors during the
study. Several studies have shown that GH was able
to increase competent cells in the immune system/
immunity directly such as lymphocytes, natural killer
cells (NK cells), and macrophages (Kelley, 1989; Gala,
1991). In rainbow trout, GH was able to increase the
resistance to bacterial infection of Vibrio anguillarum
through the enhancement of phagocytic activity (Sakai
et al., 1997). GH is also able to increase the produc-
tion of superoxide anion in leukocytes and leukocyte
mitogenesis (Sakai et al., 1996). While in gilthead sea
bream (Sparus aurata) and seabream silver (Sparus
Sarba) GH could stimulates lymphopoiesis and ph-
agocytosis (Harris & Bird, 2000). The presence of GH
receptors was also detected on lymphocytes and
monocytes of gilthead seabream (Sparus aurata)
showing that GH is directly related to the immune
system (Calduch-Giner et al., 1995).
CONCLUSION
Administration of rElGH on clown loach larvae
through immersion could significantly increase
growth length by 7.3% compared to the control. The
best immersion dose was 1.2 mg/L rElGH.
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